RxDoctor Payments Data

James Herdegen, MD

Internal Medicine · Chicago, ILNPI 1184737793

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $4,634 of the $6,530 with a category attached, or 71.0%. 9 manufacturers reported payments, led by Jazz Pharmaceuticals Inc. at 34.0% of the total. Reporting peaked in 2020 at $2,750 and has fallen 62.9% since, to $1,019 in 2025. Among internal medicine clinicians in IL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$6,530in general payments, 2019–2025

Across 19 payments — averaging $343.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Jazz Pharmaceuticals Inc.$2K
  • GE HealthCare$2K
  • Verathon Inc.$1K
  • Inspire Medical Systems, Inc.$822
  • Advanced Respiratory, Inc$360
  • Itamar Medical Inc$146
  • plus $297 from 3 others
$750in research payments, 2019–2025

Across 1 payment — averaging $750.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Resmed Corp$750

What the payments were for

  • Consulting fees$4,63471%
  • Speaking & faculty fees$3606%
  • Travel & lodging$77012%
  • Food & beverage$5809%
  • Education$1863%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,530 in reported general payments places this provider in the 90th percentile of 5,182 internal medicine providers in Illinois.

See all internal medicine providers in Illinois →

Medicare billing

Part B allowed, 2024
$50,430
Medicare patients
355
Services billed
605

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin31$228

Paid to pharmacies, not to this prescriber.

Other internal medicine in Chicago

See the full list for Illinois →

Where these figures come from

Is this you, or does something look wrong? →